ZYME
Zymeworks Inc.
NASDAQ · Healthcare · Biotechnology · CA
$29.19
−2.37%Margins
Gross margin
87.8%
EBITDA margin
-376.9%
EBIT margin
-419.0%
Net margin
-404.0%
FCF margin
-323.3%
-186.6%
Return on equity
-37.8%
Return on assets
-44.6%
Return on invested capital
0.08x
Asset turnover
-$119.1M
Cash from operations
$3.81
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026